Supplement

You have full text access to this OnlineOpen article

Understanding the burden of human papillomavirus-associated anal cancers in the US†‡

  1. Djenaba A. Joseph MD, MPH1,§,*,
  2. Jacqueline W. Miller MD1,
  3. Xiaocheng Wu MD, MPH2,
  4. Vivien W. Chen PhD2,
  5. Cyllene R. Morris DVM, PhD3,
  6. Marc T. Goodman PhD, MPH4,
  7. Jose M. Villalon-Gomez MD, MPH5,
  8. Melanie A. Williams PhD6,
  9. Rosemary D. Cress DrPh3

Article first published online: 3 NOV 2008

DOI: 10.1002/cncr.23744

Issue

Cancer

Cancer

Supplement: Assessing the Burden of HPV-Associated Cancers in the United States

Volume 113, Issue Supplement 10, pages 2892–2900, 15 November 2008

Additional Information

How to Cite

Joseph, D. A., Miller, J. W., Wu, X., Chen, V. W., Morris, C. R., Goodman, M. T., Villalon-Gomez, J. M., Williams, M. A. and Cress, R. D. (2008), Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer, 113: 2892–2900. doi: 10.1002/cncr.23744

Author Information

  1. 1

    Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia

  2. 2

    Louisiana Tumor Registry, Epidemiology Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, Louisiana

  3. 3

    Public Health Institute, California Cancer Registry, Sacramento, California

  4. 4

    Cancer Research Center, University of Hawaii, Honolulu, Hawaii

  5. 5

    Jamaica Hospital Medical Center, Mount Sinai School of Medicine Family Medicine Residency Program, New York, New York

  6. 6

    Cancer Epidemiology and Surveillance Branch, Department of State Health Services, Austin, Texas

  1. §

    Fax: (770) 488-4639.

*Centers for Disease Control and Prevention, Division of Cancer Prevention and Control, 4770 Buford Highway (K-55), Atlanta, GA 30341

  1. †

    This article is a US Government work and, as such, is in the public domain in the United States of America.

  2. ‡

    The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

Publication History

  1. Issue published online: 3 NOV 2008
  2. Article first published online: 3 NOV 2008
  3. Manuscript Accepted: 2 JUN 2008
  4. Manuscript Revised: 29 MAY 2008
  5. Manuscript Received: 14 APR 2008

Funded by

  • Cooperative Agreement. Grant Number: U50 DP424071-04
  • Centers for Disease Control and Prevention

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (138K)

REFERENCES

  • 1
    Clark MA,Hartley A,Geh JI. Cancer of the anal canal. Lancet Oncol. 2004; 5: 149–157.
  • 2
    Johnson LG,Madeleine MM,Newcomer LM,Schwartz SM,Daling JR. Anal cancer incidence and survival: the Surveillance, Epidemiology, and End Results experience, 1973-2000. Cancer. 2004; 101: 281–288.
    Direct Link:
  • 3
    Melbye M,Rabkin C,Frisch M,Biggar RJ. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol. 1994; 139: 772–780.
  • 4
    Frisch M,Melbye M. Anal cancer. In: SchottenfeldD, ed. Cancer Epidemiology and Prevention.3rd ed. New York, NY: Oxford University Press; 2006: 830–840.
  • 5
    Frisch M,Fenger C,van den Brule JC, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res. 1999; 59: 753–757.
  • 6
    Rabkin C,Biggar R,Melbye M,Curtis R. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol. 1992; 136: 54–58.
  • 7
    Frisch M,Olsen J,Melbye M. Malignancies that occur before and after anal cancer: clues to their etiology. Am J Epidemiol. 1994; 140: 12–19.
  • 8
    Frisch M. On the etiology of anal squamous carcinoma. Br Med Bull. 2002; 49: 194–209.
  • 9
    Watson M,Saraiya M,Ahmed F, et al. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of method. Cancer. 2008; 113( 10 suppl): 2841–2854.
    Direct Link:
  • 10
    Kong C,Welton M,Longacre T. Role of human papillomavirus in squamous cell metaplasia-dysplasia-carcinoma of the rectum. Am J Surg Pathol. 2007; 31: 919–925.
  • 11
    Cress RD,Holly EA. Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999. Prev Med. 2003; 36: 555–560.
  • 12
    Howe H,Jamison M,Havener L,Chen V,Ries L. Site-Specific Comparison of Summary Stage 1977 and Summary Stage 2000 Coding. Springfield, IL: The North America Association of Central Cancer Registries, 2005.
  • 13
    Phillips J. Summary stage: data effects of the changes in 2000. Available at: URL:http://www.naaccr.org/flesystem/pdf/Summary%20Stage%20Report%201-21-04b.pdf Accessed on June 7, 2007.
  • 14
    SEER*Stat Software. Surveillance Research Program, National Cancer Institute. Available at: URL: http://seer.cancer.gov/seerstat. Accessed on March 19, 2007.
  • 15
    Tiwari R,Clegg L,Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006; 15: 547–569.
  • 16
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence. SEER 13 Registries limited-use, November 2006 Submission (1992-2004). Linked to county attributes. Total U.S., 1969-2004 counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission.
  • 17
    Joinpoint Regression Program, Version 3.0. Statistical Research and Applications Branch, National Cancer Institute. Available at: http://srab.cancer.gov/joinpoint Accessed on May 1, 2007.
  • 18
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence. SEER 17 Regs limited-use, November 2006 Submision (1973-2004 varying). Linked to county attributes. Total U.S., 1969-2004 counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission.
  • 19
    Maggard MA,Beanes SR,Ko CY. Anal canal cancer: a population-based reappraisal. Dis Colon Rectum. 2003; 46: 1517–1524.
  • 20
    Daling J,Weiss N,Hislop T, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. NEngl J Med. 1987; 317: 973–977.
  • 21
    Daling J,Sherman K,Hislop T, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol. 1992; 135: 180–189.
  • 22
    Daling JR,Madeleine MM,Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 2004; 101: 270–280.
    Direct Link:
  • 23
    Frisch M,Glimelius B,van den Brule AJC, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997; 337: 1350–1358.
  • 24
    Holmes F,Borek D,Owen-Kummer M, et al. Anal cancer in women. Gastroenterology. 1988; 95: 107–111.
  • 25
    Tseng H-F,Morgenstern H,Mack T,Peters R. Risk factors for anal cancer: results of a population-based case-control study. Cancer Causes Control. 2003; 14: 837–846.
  • 26
    Edgren G,Sparen P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol. 2007; 8: 311–316.
  • 27
    Frisch M,Biggar RJ,Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000; 92: 1500–1510.
  • 28
    Melbye M,Frisch M. The role of human papillomaviruses in anogenital cancers. Semin Cancer Biol. 1998; 8: 307–313.
  • 29
    Moscicki A-B,Durako SJ,Houser J, et al. Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents. AIDS. 2003; 17: 311–320.
  • 30
    Frisch M,Goodman MT. Human papillomavirus-associated carcinomas in Hawaii and the mainland U.S. Cancer. 2000; 88: 1464–1469.
    Direct Link:
  • 31
    Hariri S,McKenna MT. Epidemiology of human immunodeficiency virus in the United States. Clin Microbiol Rev. 2007; 20: 478–488.
  • 32
    Aral SO,Fenton KA,Holmes KK. Sexually transmitted diseases in the USA: temporal trends. Sex Transm Infect. 2007; 83: 257–266.
  • 33
    Centers for Disease Control and Prevention. Tobacco use among adults—United States, 2005. MMWR Morb Mortal Wkly Rep. 2006; 55: 1145–1148.
  • 34
    Centers for Disease Control and Prevention.HIV/AIDS Surveillance Report, 2005 ed. Revised Vol. 17. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2007: 1–54.
  • 35
    McDougall J,Madeleine M,Daling J,Li C. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control. 2007; 18: 1175–1186.
  • 36
    Goldie SJ,Kuntz KM,Weinstein MC,Freedberg KA,Welton ML,Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999; 281: 1822–1829.
  • 37
    Chin-Hong PV,Palefsky JM. Human papillomavirus anogenital disease in HIV-infected individuals. Dermatol Ther. 2005; 18: 67–76.
    Direct Link:
  • 38
    Chin-Hong PV,Palefsky J. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis. 2002; 35: 1127–1134.
  • 39
    Chiao E,Giordano T,Palefsky J,Tyring S,Hashem E. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis. 2006; 43: 223–233.
View Full Article (HTML) Get PDF (138K)